Receptor group

Cannabinoid receptors

4 related receptors and the ligands measured at several of them.

Binding affinity (Kᵢ)

9 ligands measured at two or more members, human values in nM, strongest first. Select a value for its assay and source.

View
HU-210 at CB1: Kᵢ 1.7 nM, other reports differ, Govaerts SophieJ et al. 2004HU-210 at CB2: Kᵢ 1.4 nM, Govaerts SophieJ et al. 2004Nabilone at CB1: Kᵢ 2.2 nM, Gareau et al. 1996Nabilone at CB2: Kᵢ 1.8 nM, Gareau et al. 1996CP 55,940 at CB1: Kᵢ 6.6 nM, other reports differ, Govaerts SophieJ et al. 2004CP 55,940 at CB2: Kᵢ 11 nM, other reports differ, Govaerts SophieJ et al. 2004WIN 55,212-2 at CB1: Kᵢ 129 nM, Govaerts SophieJ et al. 2004WIN 55,212-2 at CB2: Kᵢ 17 nM, other reports differ, Govaerts SophieJ et al. 2004Δ⁹-THC (Tetrahydrocannabinol) at CB1: Kᵢ 20 nM, other reports differ, Wiley et al. 2024Δ⁹-THC (Tetrahydrocannabinol) at CB2: Kᵢ 52 nM, other reports differ, Wiley et al. 2024Δ⁸-THC (Tetrahydrocannabinol) at CB1: Kᵢ 36 nM, other reports differ, Wiley et al. 2024Δ⁸-THC (Tetrahydrocannabinol) at CB2: Kᵢ 50 nM, other reports differ, Wiley et al. 2024Cannabinol (CBN) at CB1: Kᵢ 285 nM, other reports differ, Wiley et al. 2024Cannabinol (CBN) at CB2: Kᵢ 163 nM, other reports differ, Wiley et al. 2024Cannabigerol (CBG) at CB1: Kᵢ 1300 nM, Zagzoog et al. 2020Cannabigerol (CBG) at CB2: Kᵢ 490 nM, other reports differ, Zagzoog et al. 2020Cannabidiol (CBD) at CB1: Kᵢ 4330 nM, other reports differ, Wiley et al. 2024Cannabidiol (CBD) at CB2: Kᵢ 2370 nM, other reports differ, Wiley et al. 2024JWH-018 at CB2: Kᵢ 2.9 nM, Aung et al. 2000CB1 receptorCB1CB2 receptorCB2HU-210, Kᵢ: CB1 1.7 nM, CB2 1.4 nMHU-210Nabilone, Kᵢ: CB1 2.2 nM, CB2 1.8 nMNabiloneCP 55,940, Kᵢ: CB1 6.6 nM, CB2 11 nMCP 55,940WIN 55,212-2, Kᵢ: CB1 129 nM, CB2 17 nMWIN 55,212-2Δ⁹-THC (Tetrahydrocannabinol), Kᵢ: CB1 20 nM, CB2 52 nMΔ⁹-THC (Tetrahydrocanna…Δ⁸-THC (Tetrahydrocannabinol), Kᵢ: CB1 36 nM, CB2 50 nMΔ⁸-THC (Tetrahydrocanna…Cannabinol (CBN), Kᵢ: CB1 285 nM, CB2 163 nMCannabinol (CBN)Cannabigerol (CBG), Kᵢ: CB1 1300 nM, CB2 490 nMCannabigerol (CBG)Cannabidiol (CBD), Kᵢ: CB1 4330 nM, CB2 2370 nMCannabidiol (CBD)JWH-018, Kᵢ: CB2 2.9 nMJWH-018
stronger weaker other reports differno line not measured or filtered out, not “inactive”

Lines connect each ligand to the members it has a displayed human Kᵢ at. The thicker and darker the line, the stronger the value. A ligand sits close to the members it binds most strongly and between those it binds about equally, so its position is only approximate. Select a ligand or a member to follow its lines, or a line to see its assay and source. The table view lists the same values.

Functional potency (EC₅₀)

9 ligands measured at two or more members, human values in nM, strongest first. Select a value for its assay and source.

View
LigandCB1 receptorCB2 receptorGPR18GPR55
Δ⁹-THC (Tetrahydrocannabinol)
HU-210not measured
CP 55,940not measured
WIN 55,212-2not measurednot measured
Cannabidiol (CBD)not measured
JWH-018not measurednot measured
Cannabigerol (CBG)not measurednot measured
Cannabinol (CBN)not measurednot measured
Δ⁸-THC (Tetrahydrocannabinol)not measurednot measured
Δ⁹-THC (Tetrahydrocannabinol) at CB1: EC₅₀ 250 nM, other reports differ, Banister et al. 2015Δ⁹-THC (Tetrahydrocannabinol) at CB2: EC₅₀ 1157 nM, other reports differ, Banister et al. 2015Δ⁹-THC (Tetrahydrocannabinol) at GPR18: EC₅₀ 960 nM, McHugh et al. 2012Δ⁹-THC (Tetrahydrocannabinol) at GPR55: EC₅₀ 8.0 nM, Ryberg et al. 2007HU-210 at CB1: EC₅₀ 0.20 nM, Ryberg et al. 2007HU-210 at CB2: EC₅₀ 0.50 nM, Ryberg et al. 2007HU-210 at GPR55: EC₅₀ 26 nM, Ryberg et al. 2007CP 55,940 at CB1: EC₅₀ 7.7 nM, other reports differ, Zagzoog et al. 2020CP 55,940 at CB2: EC₅₀ 36 nM, other reports differ, Scott et al. 2019CP 55,940 at GPR55: EC₅₀ 5.0 nM, Ryberg et al. 2007WIN 55,212-2 at CB1: EC₅₀ 18 nM, Ryberg et al. 2007WIN 55,212-2 at CB2: EC₅₀ 62 nM, Banister et al. 2015Cannabidiol (CBD) at CB1: EC₅₀ 1469 nM, Husni et al. 2014Cannabidiol (CBD) at CB2: EC₅₀ 58 nM, Zagzoog et al. 2020Cannabidiol (CBD) at GPR18: EC₅₀ of 10 µM or weakerJWH-018 at CB1: EC₅₀ 102 nM, other reports differ, Banister et al. 2015JWH-018 at CB2: EC₅₀ 133 nM, Banister et al. 2015Cannabigerol (CBG) at CB1: EC₅₀ 120 nM, Zagzoog et al. 2020Cannabigerol (CBG) at CB2: EC₅₀ 130 nM, other reports differ, Zagzoog et al. 2020Cannabinol (CBN) at CB1: EC₅₀ 307 nM, Husni et al. 2014Cannabinol (CBN) at CB2: EC₅₀ 289 nM, Husni et al. 2014Δ⁸-THC (Tetrahydrocannabinol) at CB1: EC₅₀ 5820 nM, Husni et al. 2014Δ⁸-THC (Tetrahydrocannabinol) at CB2: EC₅₀ 524 nM, Husni et al. 2014CB1 receptorCB1CB2 receptorCB2GPR18GPR18GPR55GPR55Δ⁹-THC (Tetrahydrocannabinol), EC₅₀: CB1 250 nM, CB2 1157 nM, GPR18 960 nM, GPR55 8.0 nMΔ⁹-THC (Tetrahydrocanna…HU-210, EC₅₀: CB1 0.20 nM, CB2 0.50 nM, GPR55 26 nMHU-210CP 55,940, EC₅₀: CB1 7.7 nM, CB2 36 nM, GPR55 5.0 nMCP 55,940WIN 55,212-2, EC₅₀: CB1 18 nM, CB2 62 nMWIN 55,212-2Cannabidiol (CBD), EC₅₀: CB1 1469 nM, CB2 58 nM, GPR18 10 µM or weakerCannabidiol (CBD)JWH-018, EC₅₀: CB1 102 nM, CB2 133 nMJWH-018Cannabigerol (CBG), EC₅₀: CB1 120 nM, CB2 130 nMCannabigerol (CBG)Cannabinol (CBN), EC₅₀: CB1 307 nM, CB2 289 nMCannabinol (CBN)Δ⁸-THC (Tetrahydrocannabinol), EC₅₀: CB1 5820 nM, CB2 524 nMΔ⁸-THC (Tetrahydrocanna…
stronger weaker other reports differ 10 µM or weaker (when shown)no line not measured or filtered out, not “inactive”

Lines connect each ligand to the members it has a displayed human EC₅₀ at. The thicker and darker the line, the stronger the value. A ligand sits close to the members it binds most strongly and between those it binds about equally, so its position is only approximate. Select a ligand or a member to follow its lines, or a line to see its assay and source. The table view lists the same values.

stronger weaker≥ 10 µM measured, 10 µM or weakerempty not measured* other reports differ† source not traced to the original

Human values only. A cell shows the value displayed on the compound page, from one assay. Values from different assays are not directly interchangeable, and a value does not establish clinical potency or safety.